Your browser doesn't support javascript.
loading
Impact of the Inclusion of an Aminoglycoside to the Initial Empirical Antibiotic Therapy for Gram-Negative Bloodstream Infections in Hematological Neutropenic Patients: a Propensity-Matched Cohort Study (AMINOLACTAM Study).
Albasanz-Puig, A; Gudiol, C; Puerta-Alcalde, P; Ayaz, C M; Machado, M; Herrera, F; Martín-Dávila, P; Laporte-Amargós, J; Cardozo, C; Akova, M; Álvarez-Uría, A; Torres, D; Fortún, J; García-Vidal, C; Muñoz, P; Bergas, A; Pomares, H; Mercadal, S; Durà-Miralles, X; García-Lerma, E; Pallarès, N; Carratalà, J.
Afiliação
  • Albasanz-Puig A; Infectious Disease Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Gudiol C; Infections of the Respiratory Tract and in Immunocompromised Patients Research Group, Infectious Diseases and Transplantation Program, Institut d'Investigació Biomèdica de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Puerta-Alcalde P; Spanish Network for Research in Infectious Disease, Instituto de Salud Carlos III, Madrid, Spain.
  • Ayaz CM; Infectious Disease Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Machado M; Infections of the Respiratory Tract and in Immunocompromised Patients Research Group, Infectious Diseases and Transplantation Program, Institut d'Investigació Biomèdica de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Herrera F; Spanish Network for Research in Infectious Disease, Instituto de Salud Carlos III, Madrid, Spain.
  • Martín-Dávila P; University of Barcelona, Barcelona, Spain.
  • Laporte-Amargós J; Institut Català d'Oncologia, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Cardozo C; Spanish Network for Research in Infectious Disease, Instituto de Salud Carlos III, Madrid, Spain.
  • Akova M; Infectious Diseases Department, Hospital Clínic i Provincial, Barcelona, Spain.
  • Álvarez-Uría A; Hacettepe University School of Medicine, Ankara, Turkey.
  • Torres D; Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
  • Fortún J; Infectious Diseases Section, Department of Medicine, Centro de Educación Médica e Investigaciones Clínicas, Buenos Aires, Argentina.
  • García-Vidal C; Infectious Diseases Department, Ramón y Cajal Hospital, Madrid, Spain.
  • Muñoz P; Infectious Disease Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Bergas A; Infections of the Respiratory Tract and in Immunocompromised Patients Research Group, Infectious Diseases and Transplantation Program, Institut d'Investigació Biomèdica de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Pomares H; Spanish Network for Research in Infectious Disease, Instituto de Salud Carlos III, Madrid, Spain.
  • Mercadal S; Infectious Diseases Department, Hospital Clínic i Provincial, Barcelona, Spain.
  • Durà-Miralles X; Hacettepe University School of Medicine, Ankara, Turkey.
  • García-Lerma E; Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
  • Pallarès N; Infectious Diseases Section, Department of Medicine, Centro de Educación Médica e Investigaciones Clínicas, Buenos Aires, Argentina.
  • Carratalà J; Infectious Diseases Department, Ramón y Cajal Hospital, Madrid, Spain.
Antimicrob Agents Chemother ; 65(8): e0004521, 2021 07 16.
Article em En | MEDLINE | ID: mdl-33972253

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por Bactérias Gram-Negativas / Bacteriemia / Sepse Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Antimicrob Agents Chemother Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por Bactérias Gram-Negativas / Bacteriemia / Sepse Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Antimicrob Agents Chemother Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha